ArticleAnnals of medicine2025
Correlation between CT growth patterns and invasiveness progression in neoplastic subcentimeter sub-solid nodules.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSize and/or attenuation growth of neoplastic sub-solid nodules (SSNs) potentially indicate progression in invasiveness. This study aims to clarify the correlation between growth patterns based on size and attenuation and the invasiveness progression in subcentimeter neoplastic SSNs.
methodsFrom December 2018 to October 2024, 530 patients with 629 neoplastic SSNs (initial diameter <10 mm) were retrospectively enrolled. Based on CT changes (interval ≥3 months), the lesions were divided into four groups: I, no growth in size or attenuation; II, growth in both size and attenuation; III, growth only in size; and IV, growth only in attenuation. The relationship between growth patterns and pathological results was investigated, and the key CT indicators suggestive of invasiveness progression were determined.
resultsLesions in groups I, II, III, and IV were 424 (67.4%), 76 (12.1%), 84 (13.4%), and 45 (7.1%), respectively. The invasive adenocarcinomas (IACs) and invasive lesions (ILs) were more prevalent in groups II (38.2%, 78.9%) and III (11.9%, 52.4%) compared to group I (3.8%, 34.0%) (all
conclusionRegarding the subcentimeter SSNs, size growth, especially with concurrent attenuation increase, indicate a higher possibility of invasiveness progression, with mass being the primary predictor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.